If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMEDI.L Regulatory News (MEDI)

  • There is currently no data for MEDI

Contract gains and trading update

6 Jul 2009 07:00

RNS Number : 1400V
Medilink-Global UK Limited
06 July 2009
Β 

6 July 2009

MEDILINK-GLOBAL UK LIMITED

Trading Update - Contract gains

Medilink-Global UK Limited ("MediLink"),Β the electronic health card network service provider, is pleased to announce the following contract gains with the joint venture AVIVA-COFCO in China, QualitasΒ Medical GroupΒ and AXA-Affin in Malaysia.

Background

MediLink hasΒ launchedΒ threeΒ healthcare related productsΒ all or in part of which are included in the contract gains mentioned in this release.Β The products are Emergency Medical Assistance Service FacilitationΒ ("EMA"), Medical Second OpinionΒ ("MSO"), and Medical Tourism / Cross Border Care Facilitation. These will be packaged as value-added services to its core Third Party Administrator ("TPA") services or as stand-alone products.Β The contractΒ and strategic allianceΒ winsΒ in this release are set toΒ provide the Company with a platform to generate future sales.Β 

Contract gains

AVIVA-COFCOΒ 

MediLink's wholly owned subsidiaryΒ MediLink (Beijing) TPA Services Co. Ltd ("MedilinkΒ Beijing") hasΒ entered into a contract to provide Third Party Administration ("TPA") services to AVIVA-COFCOΒ Life Insurance Co. Ltd. ("AVIVA-COFCO").Β AVIVA-COFCOΒ isΒ a joint venture between AVIVA, the world's fifth-largest insurance providerΒ andΒ COFCO Limited, theΒ largestΒ oil and foodΒ importer and exporter in China, and has operations in over 40 cities in China. The contract will run for 3 years after which it is subject to automatic renewal for a further 3 years.Β AVIVA-COFCO will promote MediLink's TPA services through its agencies, brokers and banks.

MediLink Beijing is contracted to provide a comprehensive package of TPA services using an Electronic Claims Clearing System, MediLink's bespoke Claim Application System, and its exclusive Electronic Data Capture healthcare provider network, with services that include cashless hospitalisation, direct billing medical claim processing amongst other services to enhance efficiencies.

TheΒ contract also includes the provisioning ofΒ MediLink'sΒ MSOΒ serviceΒ whichΒ enables membersΒ to seekΒ aΒ second opinion fromΒ anyΒ of theΒ worldΒ leading Medical Centres of ExcellenceΒ around the world.Β MSO acts as a veryΒ cost effectiveΒ and convenient wayΒ for theΒ insured to seekΒ aΒ second opinion.

Licensing of MediLink's Claims Technology to QualitasΒ MedicalΒ Group

MGA has also entered into a Technology License Agreement with Qualitas Medical Group ("Qualitas"), the largest well-integrated network of primary care and out-patient service provider in Malaysia. Under the agreement all Qualitas Clinics will use MediLink's entire suite of web-based Claims Application System to control utilisation, verify eligibility and process claims for employers' funded Out-Patient Healthcare Plans which are managed by Qualitas. This agreement allows Medilink to earn a transaction fee for clinic visitation and opens up a significant market channel and revenue stream for the company.Β 

Maiden strategic collaboration

MediLink's subsidiary, Medilink-Global Asia Pte Ltd (MGA) has signed its first strategic collaboration agreement with a medical centre of excellence in Malaysia, Sime Darby Medical Centre, to promote and facilitate Medical Tourism and Cross-border healthcare services. This collaboration represents the first step taken by the MGA in launching itself as a global facilitator of cross-border care.

Service agreement with AXA-AffinΒ MalaysiaΒ 

MediLink'sΒ wholly owned subsidiary in Malaysia, Datalink Healthcard Network Sdn Bhd,Β hasΒ securedΒ itsΒ firstΒ EMA facilitation contract with AXA Affin General Insurance Berhad ("AXA Affin"), one of the major insurers in Malaysia.Β EMA servicesΒ includeΒ aΒ 24Β hourΒ medical help-line, cross border medical care facilitation and arrangement, medical referral, counselling,Β monitoring, evacuation,Β andΒ repatriation.Β 

Shia Kok Fat, CEO of MediLink, commented:Β "We are extremely pleased to have won the contract with AVIVA. This is proof our expansion strategy in China is working and this contract will greatly enhance MediLink's standing in China and so help drive further growth.Β MSOΒ is an important part of the fast growing cross borderΒ medicalΒ industry of which MediLink is aiming to beΒ a leader in helpingΒ facilitateΒ and in which we see great potential for growth. WeΒ feelΒ ourΒ added value initiatives will help grow the Group's revenue streamΒ by enhancing our coreΒ TPAΒ services.Β 

We now haveΒ 700 healthcare providers on our networkΒ which means we are well placed to meet our forecast to grow from 164 to 1,000 by the end of 2009."Β 

Enquiries

MediLink-Global UK Limited

Broker

Shia Kok Fat,Β Chief Executive Officer

SVS SecuritiesΒ plc

Tel: 00 603 2296 3028

Ian Callaway,Β Head of Corporate Broking

Tel: 020 7382 2870

Nominated AdviserΒ 

Dowgate Capital Advisers Limited

Financial Public Relations

Liam MurrayΒ or Jo Turner

Walbrook PR Ltd

Tel: 020 7492 4777

Ben Knowles

Tel: 020 7933 8788Β or Mob. 07900 346 978

ben.knowles@walbrookpr.com

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
MSCUVUWRKWRBRAR
12
Date   Source Headline
6th Jun 201710:43 amRNSResult of EGM
15th May 20177:00 amRNSUpdate re proposed cancellation and notice of EGM
3rd Apr 20179:37 amRNSCompletion of disposal of stake in Medilink China
17th Mar 201711:40 amRNSDivestment of stake in Medilink China
22nd Dec 201611:51 amRNSVariation to terms of existing loan facility
9th Nov 20167:00 amRNSUpdate re proposed cancellation from AIM
29th Sep 20163:24 pmRNSHalf-year Report
6th Sep 201610:58 amRNSResult of AGM
11th Aug 201611:40 amRNSNotice of AGM
27th Jul 20169:00 amRNSIntention to seek cancellation from trading on AIM
27th Jun 20162:53 pmRNSFinal Results
20th May 201611:00 amRNSStatement re share price movement
14th Jan 20169:30 amRNSAgreement with Etiqa Insurance Berhad
27th Oct 201510:15 amRNSResult of AGM
1st Oct 20157:00 amRNSHalf Yearly Report
1st Oct 20157:00 amRNSFinal Results
18th Jun 20152:00 pmRNSSuspension - Medilink-Global UK Limited
18th Jun 20152:00 pmRNSStatement re. Suspension
11th Nov 20149:12 amRNSVariation to terms of loan facility
30th Sep 20143:58 pmRNSTotal Voting Rights
19th Sep 20149:50 amRNSHalf Yearly Report
2nd Sep 20145:19 pmRNSIssue of Equity
1st Aug 201411:15 amRNSDivestment of stake in Medilink China
17th Jul 201411:30 amRNSResult of AGM
27th Jun 20145:15 pmRNSFinal Results
26th Feb 20147:00 amRNSCollaboration Agreement with HIMSS-Asia Pacific
2nd Oct 20131:03 pmRNSApplication of the Takeover Code
25th Sep 20137:00 amRNSHalf Yearly Report
29th Jul 20139:44 amRNSResult of AGM
28th Jun 20137:00 amRNSFinal Results
10th Jan 20139:15 amRNSDirector re-designation
15th Oct 201210:30 amRNSResult of AGM
28th Sep 201210:10 amRNSHalf Yearly Report
5th Sep 201211:00 amRNSRestoration - Medilink Global UK Ltd
5th Sep 201211:00 amRNSFinal Results
30th Aug 201210:28 amRNSHolding(s) in Company
20th Aug 20125:10 pmRNSHolding in Company
17th Aug 20121:30 pmRNSTrading update
2nd Jul 20128:16 amRNSHolding(s) in Company
29th Jun 20127:31 amRNSStatement re. Suspension
29th Jun 20127:30 amRNSSuspension - Medilink-Global UK Limited
12th Jun 20123:00 pmRNSHolding in Company
6th Jun 201211:45 amRNSDirectorate Changes
21st Mar 20123:52 pmRNSHoldings in Company and Director Shareholding
19th Mar 20124:15 pmRNSLoan facility and related party transaction
30th Nov 20119:09 amRNSTotal Voting Rights
9th Nov 20117:00 amRNSIssue of Equity and Directors' shareholdings
28th Sep 20112:45 pmRNSHalf Yearly Report
26th Jul 20119:15 amRNSResult of AGM
4th Jul 20112:00 pmRNSHolding(s) in Company
12

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.